111 (NASDAQ:YI – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.04) earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $527.14 million for the quarter.
111 Price Performance
Shares of YI opened at $10.49 on Friday. The firm has a market capitalization of $89.71 million, a PE ratio of -2.62 and a beta of 0.46. 111 has a 1-year low of $4.15 and a 1-year high of $14.10. The company’s fifty day moving average price is $7.22 and its 200-day moving average price is $7.32.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 111 in a report on Friday, March 7th.
About 111
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
See Also
- Five stocks we like better than 111
- How to Calculate Return on Investment (ROI)
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How to Calculate Inflation Rate
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- MarketBeat Week in Review – 03/17 – 03/21
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
